Chemistry - A European Journal
10.1002/chem.201602957
COMMUNICATION
[
13]
(a) T. G. Gant, A. I. Meyers, Tetrahedron 1994, 50, 2297-2360; (b)
G. S. K. Wong, W. Wu, in Oxazoles: Synthesis, Reactions, and
Spectroscopy, John Wiley & Sons, Inc., 2004, pp. 331-528.
methyl group was successfully used for the inversion of
configuration at
a quaternary stereocenter of the readily
available epimeric synthetic intermediate. Although this
transformation required 2 additional steps for the formation of
the directing oxazoline group and 4 steps were necessary to
reduce the directing group to methyl, the developed approach
allowed the preparation of the challenging compound 3 in an
acceptable 8.5% overall yield.
[14]
H. Vorbrüggen, K. Krolikiewicz, Tetrahedron Lett. 1981, 22, 4471-
4474.
[
15]
For examples of palladium-catalyzed C-H functionalyzation of
substrates with alkenyl fragments, see: (a) M. Wasa, J.-Q. Yu, J.
Am. Chem. Soc. 2008, 130, 14058-14059; (b) S.-Y. Zhang, G. He,
Y. Zhao, K. Wright, W. A. Nack, G. Chen, J. Am. Chem. Soc. 2012,
1
34, 7313-7316; (c) G. Shan, X. Yang, Y. Zong, Y. Rao, Angew.
Chem. 2013, 125, 13851-13855; Angew. Chem. Int. Ed. Engl.
013, 52, 13606-13610; (d) W.-H. Rao, B.-B. Zhan, K. Chen, P.-X.
2
Ling, Z.-Z. Zhang, B.-F. Shi, Org. Lett. 2015, 17, 3552-3555.
A. F. S. André, H. B. MacPhillamy, J. A. Nelson, A. C. Shabica, C.
R. Scholz, J. Am. Chem. Soc. 1952, 74, 5506-5511.
[
[
16]
17]
Acknowledgements
(a) M. Tanabe, D. F. Crowe, J. Org. Chem. 1963, 28, 3197-3199;
(b) V. A. Khripach, V. N. Zhabinskii, A. I. Kotyatkina, G. P. Fando,
A. S. Lyakhov, A. A. Govorova, M. Groen, J. van der Louw, A. de
Groot, Mendeleev Commun. 2001, 144-145.
K. Schwekendiek, F. Glorius, Synthesis 2006, 2006, 2996-3002.
K. B. Sharpless, M. A. Umbreit, M. T. Nieh, T. C. Flood, J. Am.
Chem. Soc. 1972, 94, 6538-6540.
J. Fried, J. A. Edwards, Organic Reactions in Steroid Chemistry,
Van Nostrand Reinhold Comp., New York, 1972.
L. F. Fieser, J. Am. Chem. Soc. 1953, 75, 5421-5422.
D. H. R. Barton, D. J. Lester, S. V. Ley, J. Chem. Soc., Perkin
Trans. 1 1980, 2209-2212.
The financial support of the Belarusian Foundation for Funda-
mental Research (project X16-107) is greatly appreciated. We
thank Dr. Alexander Baranovsky (Institute of Bioorganic
Chemistry) for assistance with NMR spectroscopy, Dr. Aliaksei
Yantsevich (Institute of Bioorganic Chemistry) for high resolution
mass spectrometric analysis.
[18]
19]
[
[20]
[
[
21]
22]
[
[
23]
24]
K. Chen, C. Liu, L. Deng, G. Xu, Steroids 2010, 75, 513-516.
C NMR spectral data of the synthesized compound were in a
Keywords: C-H activation • steroids • rearrangement • oxidation •
13
good agreement with those reported for 20OH-NorMD (3) obtained
protecting groups
[
1b, c]
by biotechnological approach
while small chemical shift
1
differences were observed in the H NMR spectra (see SI).
[
1]
(a) W. Schänzer, H. Geyer, G. Fußholler, N. Halatcheva, M. Kohler,
M.-K. Parr, S. Guddat, A. Thomas, M. Thevis, Rapid Commun.
Mass Spectrom. 2006, 20, 2252-2258; (b) A. Zöllner, M. K. Parr,
C.-A. Drăgan, S. Dräs, N. Schlörer, F. T. Peters, H. H. Maurer, W.
Schänzer, M. Bureik, J. Biol. Chem. 2010 391, 119-127; (c) M. K.
Parr, A. Zöllner, G. Fussholler, G. Opfermann, N. Schlörer, M.
Zorio, M. Bureik, W. Schänzer, Toxicol. Lett. 2012, 213, 381-391.
For detection of 17β-hydroxymethyl-17α-methyl-18-norandrost-13-
ene human metabolites of 17-methylated AAS (oxandrolone,
DHCMT, methyl-1-testosterone and methyltestosteron), and for
formation of steroids with analogous D-ring by biotransfornation of
[
2]
1
7,17-dimethyl-18-norandrost-13-enes, see: (a) M. K. Parr, G.
Fußhöller, M. Gütschow, C. Hess., W. Schänzer, in Recent
advances in doping analysis (18), Sportverlag Strauß, Cologne,
010, 64-73; for biotechnological synthesis of and its full
2
4
characterization, see: (b) Guddat, G. Fußhöller, S. Beuck, A.
Thomas, H. Geyer, A. Rydevik, U. Bondesson, M. Hedeland, A.
Lagojda, W. Schänzer, M. Thevis, Anal. Bioanal. Chem. 2013 405,
8
285-8294.
H. Geyer, W. Schänzer, M. Thevis, Br. J. Sports Med. 2014, 48,
20-826.
[
[
3]
4]
8
For detection of 5a, 5b and further DHCMT metabolites with similar
D-ring, see: (a) T. Sobolevsky, G. Rodchenkov, J. Steroid Biochem.
Mol. Biol. 2012, 128, 121-127; (b) M. Fernández-Álvarez, J. Lu, D.
Cuervo, Y. Xu, J. Muñoz-Guerra, R. Aguilera, in Recent advances
in doping analysis (22), Sportverlag Strauß, Cologne, 2014, 182-
187.
[
[
5]
6]
T. Sobolevsky, G. Rodchenkov, Drug Test. Anal. 2012, 4, 682-691.
W. Abushareeda, A. Fragkaki, A. Vonaparti, Y. Angelis, M. Tsivou,
K. Saad, S. Kraiem, E. Lyris, M. Alsayrafi, C. Georgakopoulos,
Bioanalysis 2014, 6, 881-896.
[
[
7]
8]
(a) D. N. Kirk, M. A. Wilson, J. Chem. Soc. C 1971, 414-424; (b) J.
R. Bull, L. M. Steer, Tetrahedron 1990, 46, 5389-5400.
(a) D. M. P. E. Caspi, Can. J. Chem. 1963, 41, 2294-2298; (b) W.
Schänzer, G. Opfermann, M. Donike, Steroids 1992, 57, 537-550;
(
c) D. G. Loughhead, J. Org. Chem. 1985, 50, 3931-3934; (d) G. R.
Pettit, R. F. Mendonça, J. C. Knight, R. K. Pettit, J. Nat. Prod. 2011,
4, 1922-1930; (e) C.-X. Huang, Y. Shi, J.-R. Lin, R.-H. Jin, W.-S.
7
Tian, Tetrahedron Lett. 2011, 52, 4123-4125; (f) G. Deniau, K. T.
Sillar, D. O’Hagan, J. Fluorine Chem. 2008, 129, 881-887.
(a) J. F. Hartwig, J. Am. Chem. Soc. 2016, 138, 2-24; (b) T.
Newhouse, P. S. Baran, Angew. Chem. 2011, 123, 3422-3435;
Angew. Chem. Int. Ed. 2011, 50, 3362-3374; (c) D. Y. K. Chen, S.
W. Youn, Chem. Eur. J. 2012, 18, 9452-9474; (d) Y. Qiu, S. Gao,
Natural Product Reports 2016, 33, 562-581.
[
[
9]
10]
(a) T. W. Lyons, M. S. Sanford, Chem. Rev. 2010, 110, 1147-
1169; (b) X. Yang, G. Shan, L. Wang, Y. Rao, Tetrahedron Lett.
2016, 57, 819-836.
[
[
11]
12]
G. Drefahl, K. Ponsold, H. Schick, Chem. Ber. 1964, 97, 3529-
535.
R. Giri, J. Liang, J. G. Lei, J. J. Li, D. H. Wang, X. Chen, I. C.
3
Naggar, C. Guo, B. M. Foxman, J. Q. Yu, Angew. Chem. 2005,
117, 7586-7590; Angew. Chem. Int. Ed. Engl. 2005, 44, 7420-7424.